Sign Up

Sign up to our social GMP Questions and Answers Engine to ask and answer questions, and connect with other professionals.

Have an account? Sign In
or use


Have an account? Sign In Now

Sign In

Login to our social GMP Questions and Answers Engine to ask and answer questions and connect with other professionals.

Sign Up Here
or use

Forgot Password?

Don't have account, Sign Up Here

Forgot Password

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.


Have an account? Sign In Now
You must login to ask question.

or use

Forgot Password?

Need An Account, Sign Up Here
Qualistery – GMP Knowledge Provider Logo Qualistery – GMP Knowledge Provider Logo
Sign InSign Up

Qualistery – GMP Knowledge Provider

Qualistery – GMP Knowledge Provider Navigation

  • Home
  • GMP Learning
    • Live GMP Webinars
    • Webinar Recordings
  • Resources
    • Articles
    • Podcast
  • Speaking & Sponsorship
    • Speaking Partners (Organization)
    • Event Sponsorship
    • Speaking and Training Opportunities For GxP Experts
  • Contact
  • My Account
Search
Ask A Question

Mobile menu

Close
Ask a Question
  • Home
  • GMP Learning
    • Live GMP Webinars
    • Webinar Recordings
  • Resources
    • Articles
    • Podcast
  • Speaking & Sponsorship
    • Speaking Partners (Organization)
    • Event Sponsorship
    • Speaking and Training Opportunities For GxP Experts
  • Contact
  • My Account
Home/ Questions/Q 705
In Process
Adv
Qualistery
  • 0
QualisteryLevel 2
Asked: August 11, 20212021-08-11T14:00:03+02:00 2021-08-11T14:00:03+02:00

Who is responsible for analytically testing APIs to ensure they comply with their specifications and with USP requirements, if any?

  • 0
Who is responsible for analytically testing APIs to ensure they comply with their specifications and with USP requirements, if any?
APIsusp
  • 1 1 Answer
  • 95 Views
  • 0 Followers
  • 0
Answer
Share
  • Facebook
    Adv

    1 Answer

    • Voted
    • Oldest
    • Recent
    • Random
    1. Qualistery Level 2
      2021-08-12T04:48:51+02:00Added an answer on August 12, 2021 at 4:48 am
      This answer was edited.

      API manufacturers perform analytical testing on APIs to confirm that they meet all applicable specifications established for release. Finished drug product manufacturers ensure that APIs used in their products meet all of their established specifications and—for compendial APIs—meet USP requirements. Additional information is provided below.

      API Manufacturer Responsibilities
      Section 501(a)(2)(B) of the FD&C Act requires all drugs (including APIs) to be manufactured in compliance with CGMP. FDA, therefore, expects API manufacturers to follow the recommendations in ICH guidance for industry Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients.   API labeling supplied by the API manufacturer includes a certificate of analysis (COA). Section 11.4 of ICH Q7 recommends that the API manufacturer’s COA should include, as applicable, the API’s name, grade, batch/lot number, date of release, and a list of “each test performed in accordance with compendial or customer requirements, including the acceptance limits, and the numerical results obtained . . . .” For example, for a compendial-grade API, the COA should identify the compendial tests that were performed (as well as customer-specified tests, if any) and the test results. If a compendial-grade API differs from a USP standard of strength, quality, or purity, that difference should be clearly declared on the label.

      Finished Drug Product Manufacturer Responsibilities
      In the CGMP regulations for finished pharmaceuticals, 21 CFR 211.80 states that “[T]here shall be written procedures describing in sufficient detail the . . . testing . . . of [finished drug product] components . . . .” Additionally, 21 CFR 211.84(d)(2) states that “[E]ach component shall be tested for conformity with all appropriate written specifications for purity, strength, and quality. In lieu of such testing by the manufacturer, a report of analysis may be accepted from the supplier of a component, provided that at least one specific identity test is conducted on such component by the manufacturer, and provided that the manufacturer establishes the reliability of the supplier’s analyses through appropriate validation of the supplier’s test results at appropriate intervals.” Therefore, if the finished drug product manufacturer accepts the test results from an API supplier’s COA rather than performing the tests itself (other than for identity, which the manufacturer is required to perform), the manufacturer must validate the API supplier’s reliability. This validation procedure is established by the finished drug product manufacturer and should be consistent with the principles of CGMP and risk management. The finished drug product manufacturer should also ensure that compendial-grade APIs comply with compendial specifications, either by testing the APIs or by validating API suppliers’ reliability, as described above.

      References:

      • FD&C Act Chapter V: Drugs and Devices
      • 21 CFR 211.80: General requirements
      • 21 CFR 211.84: Testing and approval or rejection of components, drug product containers and closures
      • FDA Guidance for Industry, 2001, ICH Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
      • 0
      • Reply
      • Share
        Share
        • Share on Facebook
        • Share on Twitter
        • Share on LinkedIn
        • Share on WhatsApp

    Leave an answer
    Cancel reply

    You must login to add an answer.

    or use

    Forgot Password?

    Need An Account, Sign Up Here
    Adv

    Sidebar

    Ask A Question

    Stats

    • Questions 103
    • Answers 117
    • Best Answer 1
    • Users 71
    • Popular
    • Answers
    • Anonymous

      tablet hardness

      • 5 Answers
    • Qualistery

      What is Data Governance?

      • 3 Answers
    • Qualistery

      What is data life cycle?

      • 2 Answers
    • Md.Mahamudul Hossain Robin
      Md.Mahamudul Hossain Robin added an answer It is Completely depends on the design . There is… December 7, 2022 at 4:53 am
    • Yan Kugel
      Yan Kugel added an answer Dear Nadia, a recall is an action which the manufacturer… October 8, 2021 at 5:20 pm
    • Marc García Gómez
      Marc García Gómez added an answer Pharmaceutical manufacturers must demonstrate that bacterial, fungal, and yeast contamination… October 3, 2021 at 12:31 pm

    Top Members

    Yan Kugel

    Yan Kugel

    • 0 Questions
    • 88 Points
    Level 2
    Qualistery

    Qualistery

    • 85 Questions
    • 78 Points
    Level 2
    Shashi Ravi Suman Rudrangi, RPh

    Shashi Ravi Suman Rudrangi, RPh

    • 0 Questions
    • 33 Points
    Level 1

    Trending Tags

    Active Pharmaceutical Ingredient Airlock ALCOA+ analytical api APIs archiving A true copy audit trail Authorized Person Batch Batch Records Batch Recovery batch reworking Bracketing Calibration capa CGMP Change Control Clean Area cleaning cold chain monitoring Confirmation Testing Consignment contact lens solution Contamination Control Strategy Corrective Action Cross Contamination Data Governance data life cycle Delivery Design Space document retention schedule Drug Master File effectiveness electronic signature finished Pharmaceutical Product flexible intravenous glass GMP gmp&iso 9001 Good Manufacturing Practices good practices (GxP) hbel HBELs healthbased exposure limit health based exposure limit in-process control (IPC) In Process Control InterCompany Transfer Intermediate Product lamellae Large Volume Parenterals manufacturers manufacturing Marketing Authorization medical device medicinal metadata Operational Qualification Packaging Packaging Material pathogenic Performance Qualification Pharmaceutical manufacturers Pharmaceutical Manufacturing Pharmaceutical Product Pharmaceutical Production Pharmacopeia pq PQR process validation Product products QA QC Qualification Quality Assurance Quality Control Quality Planning quality policy quality risk management (QRM) Quality Unit Quarantine question raw material Reconciliation Reprocessing Sampling Self Contained Area single product solution bags sop special Specification Standard Operating Procedure starting material supplier qualifications supplier quality suppliers technology transfer usp Validation validation batches Validation batches in a Technology transfer Validation Master Plan validation report vp vr

    Explore

    • Home
    • Add group
    • Groups page
    • Communities
    • Questions
      • New Questions
      • Trending Questions
      • Must read Questions
      • Hot Questions
    • Polls
    • Tags
    • Badges

    Footer

    Qualistery - GMP Knowledge Provider

    Qualistery is a GMP knowledge database, and a social Questions & Answers engine which will help you dominate the arena.

    Company

    • About Us
    • Contact Us

    Legal

    • Impressum – Legal Disclosure
    • Privacy Policy
    • Cookie Policy
    • Terms and Conditions
    • Disclaimer

    Services

    • GMP Online Education

    GMP Resources

    • Articles
    • Podcast

    Follow

    © 2022 Qualistery. All Rights Reserved

    Insert/edit link

    Enter the destination URL

    Or link to existing content

      No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.